Oxymed, one of India’s most trusted names in home oxygen concentrators, has announced the launch of Oxymed Cure, a new 5 LPM oxygen concentrator designed to make reliable oxygen therapy more affordable without compromising on medical or service standards.
Oxymed has been a dominant force in the category for several years, with its flagship Oxymed Mini (5 LPM) emerging as one of the most successful oxygen concentrators in India and commanding over 50% market share in its segment. Headquartered in Bengaluru, Oxymed manufactures its products in India and has built a strong reputation for quality, transparency, and dependable after-sales support.
With an expected end-user price of Rs 32,000–33,000, Oxymed Cure is positioned nearly 15% lower than the Oxymed Mini, which typically retails at Rs 39,000–40,000.
Despite the lower price, Oxymed has retained its industry-leading 3-year warranty, a feature rarely seen in the affordable oxygen segment. The move reflects Oxymed’s understanding of India’s price-sensitive healthcare landscape, particularly for patients requiring long-term oxygen therapy.
Oxymed Cure delivers medical-grade oxygen purity of 93% ±3%, in line with global standards. It features a built-in Oxygen Purity Analyzer (OPA) that allows users to monitor real-time oxygen purity, along with an integrated nebulizer for added clinical convenience. The concentrator also offers improved energy efficiency, consuming approximately 200 watts, significantly lower than earlier models, and does not require a stabiliser.
Designed for home comfort, Oxymed Cure features a modern, premium design with a larger display, a sturdier build, and quieter operation at around 35 dB. Backed by Oxymed’s PAN-India service network, the launch positions Cure as a strong alternative to low-cost imported concentrators that often come with limited warranty and service support.
